Nigeria, March 12 -- Nigeria has received its first shipment of the long-acting injectable drug Lenacapavir for HIV prevention, marking a significant step in expanding the country's prevention options.

The development was announced in a statement issued on Wednesday by the National AIDS, Viral Hepatitis and STIs Control Programme (NASCP) under the Federal Ministry of Health and Social Welfare.

According to the ministry, the injectable drug arrived in the country on Tuesday. It will be used for pre-exposure prophylaxis (PrEP), a preventive treatment for people at risk of HIV infection.

The agency said the milestone, approved by the coordinating minister of health and social welfare, Muhammad Pate and supported by the Global Fund, repres...